Benitec BiopharmaBNTC
13F holders, Q2 2024 (June 30)18holders +5
6new positions
1sold out
$6.97avg. 13F price*
At the end of Q2 2024, 18 institutions reported holding Benitec Biopharma Inc. (BNTC) in their 13F filings, up 5 from Q1 2024. 6 opened new positions and 1 sold out. The largest holders were Montanova Capital, LLC ($11.8M), Janus Henderson Group PLC ($6.2M) and Nantahala Capital Management, LLC ($5.9M).
- Company
- Benitec Biopharma Inc.
- CUSIP
- 08205P209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $8.4M |
| Exits | 1 | $89 |
All 13F filers, Q1 2024 → Q2 2024: 4,465,693 shares bought and 7,071 shares sold, net +4,458,622 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Montanova Capital, LLC | 0.48% | Add +728.2% | 1,691,290 | $11.8M |
| Janus Henderson Group PLC | 0.00% | Add +268.4% | 900,816 | $6.2M |
| Nantahala Capital Management, LLC | 0.59% | New | 841,395 | $5.9M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | Add +344.7% | 841,395 | $5.9M |
| Franklin Resources Inc. | 0.00% | Add +35.4% | 796,644 | $5.6M |
| Schonfeld Strategic Advisors LLC | 0.01% | New | 260,417 | $1.8M |
| Vanguard Group Inc. | 0.00% | Add +1187.8% | 215,070 | $1.5M |
| Geode Capital Management, LLC | 0.00% | Add +538.2% | 63,975 | $447K |
| Simplify Asset Management Inc. | 0.03% | New | 51,216 | $358K |
| BlackRock Inc. | 0.00% | New | 28,004 | $196K |
| Northern Trust Corp. | 0.00% | New | 24,924 | $174K |
| Morgan Stanley | 0.00% | Reduce -52.5% | 5,600 | $39K |
| GAMMA Investing LLC | 0.01% | Add +53.0% | 5,438 | $38K |
| UBS Group AG | 0.00% | Add +296.9% | 2,032 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -48.9% | 891 | $6K |
| Rhumbline Advisers | 0.00% | No change | 186 | $1K |
| Group One Trading LLC | 0.00% | No change | 89 | $622 |
| Bank of America Corp. | 0.00% | New | 77 | $538 |
"% of holder's portfolio" is BNTC's weight in each manager's 13F, not the share of Benitec Biopharma Inc. the manager owns.